The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes.

This glucagon-like peptide-1 GLP-1 receptor agonist is generally administered via injection to treat type 2 diabetes and obesity. However, the company's launch of the world's first oral ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

In fact, you likely know someone who gets peptide injections daily if they use insulin for diabetes; insulin is a polypeptide hormone. Over the past decade, advancements in peptide research have ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

Inner Mongolia Key Laboratory for Molecular Regulation of the Cell, School of Life Sciences, Inner Mongolia University, Hohhot 010020, PR China ...

Results—Peptide infusions produced the desired hormone ... the effect of GLP-1 on glucose turnover in patients with type 2 diabetes, and these changes explain the glucose-lowering effect of ...

The medicine's popularity has been driven by endorsements from celebrities and influencers. Read more at straitstimes.com.

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...